The outcomes of refractory glaucoma surgery using collagen bio-implant
Aim. To analyze the efficacy of Ologen® Collagen Matrix Implant in refractory glaucoma surgery.Materials and methods. Classical non-penetrating deep sclerectomy (NPDS) with Ologen® implantation in the scleral bed was performed.Results. Post-op, implant was visualized underneath the conjunctiva and m...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Ophthalmology Publishing Group
2014-07-01
|
| Series: | Oftalʹmologiâ |
| Subjects: | |
| Online Access: | https://www.ophthalmojournal.com/opht/article/view/25 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Aim. To analyze the efficacy of Ologen® Collagen Matrix Implant in refractory glaucoma surgery.Materials and methods. Classical non-penetrating deep sclerectomy (NPDS) with Ologen® implantation in the scleral bed was performed.Results. Post-op, implant was visualized underneath the conjunctiva and moved within the scleral flap. Implant was resolved in 3 months with moderate filtering bleb formation. Following 12 months, visual acuity and visual fields were stable, IOP level was 12‑17 mm Hg.Conclusion. Within 12‑months follow-up, Ologen® implantation in the course of glaucoma surgery prevents scleral conjunctival scarring, provides long-term IOP-lowering effect and preserves residual visual functions. |
|---|---|
| ISSN: | 1816-5095 2500-0845 |